| NCT ID | NCT07190976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Attikon Hospital |
| Condition | Epilepsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-03-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Τhe aim of the study is to investigate the role of EEG both in predicting epileptogenesis in patients with acute stroke and in detecting and clarifying the clinical significance of subclinical epileptic seizures in a stroke unit. More specifically, the performance of routine EEG in patients with ischemic or hemorrhagic stroke who are hospitalized in the Stroke Unit within the first days after the event, regardless of the presence of clinical indications, and the identification of risk factors for the early development of epilepsy in the course of these patients' disease constitute the central research question. The identification of patients with subclinical electroencephalographic seizures and the impact of such events on functional outcome, as well as their association with the development of epilepsy, are set as secondary research objectives.
Eligibility Criteria
Inclusion Criteria: Patients over 18 years of age with confirmed acute ischemic or hemorrhagic stroke are eligible for inclusion in the study. Patients whose clinical presentation mimics that of a stroke will be included until the diagnosis of stroke is ruled out, at which point they will be excluded from the study. \- Exclusion Criteria: \-
Frequently Asked Questions
Who can join the NCT07190976 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07190976 currently recruiting?
Yes, NCT07190976 is actively recruiting participants. Visit ClinicalTrials.gov or contact Attikon Hospital to inquire about joining.
Where is the NCT07190976 trial being conducted?
This trial is being conducted at Chaïdári, Greece.
Who is sponsoring the NCT07190976 clinical trial?
NCT07190976 is sponsored by Attikon Hospital. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.